Daxor Co. (NASDAQ:DXR) Short Interest Update

Daxor Co. (NASDAQ:DXRGet Free Report) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 8,100 shares, a growth of 9.5% from the February 29th total of 7,400 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average daily volume of 3,000 shares, the days-to-cover ratio is currently 2.7 days.

Daxor Price Performance

DXR stock traded down $0.23 during trading on Wednesday, reaching $8.57. 1,661 shares of the company traded hands, compared to its average volume of 2,517. The business has a 50 day simple moving average of $8.38 and a 200 day simple moving average of $8.56. Daxor has a 12 month low of $7.11 and a 12 month high of $13.13.

About Daxor

(Get Free Report)

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.

Featured Stories

Receive News & Ratings for Daxor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daxor and related companies with MarketBeat.com's FREE daily email newsletter.